Insider Transactions in Q1 2025 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2025
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
2,907
-1.18%
|
$58,140
$20.81 P/Share
|
|
Jan 07
2025
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,907
-1.63%
|
$58,140
$20.81 P/Share
|
|
Jan 07
2025
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
3,339
-11.48%
|
$66,780
$20.81 P/Share
|
|
Jan 07
2025
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Direct |
7,650
-2.93%
|
$153,000
$20.81 P/Share
|
|
Jan 06
2025
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
12,255
-4.72%
|
$245,100
$20.22 P/Share
|
|
Jan 06
2025
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,255
-6.42%
|
$245,100
$20.22 P/Share
|
|
Jan 06
2025
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Direct |
29,266
-10.09%
|
$585,320
$20.22 P/Share
|
|
Jan 03
2025
|
Carole Ho Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,180
+22.11%
|
-
|
|
Jan 03
2025
|
Alexander O. Schuth COFO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
54,180
+17.27%
|
-
|
|
Jan 03
2025
|
Ryan J. Watts President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
54,180
+15.74%
|
-
|
|
Jan 02
2025
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
3,080
-2.77%
|
$61,600
$20.91 P/Share
|